摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-氟苄基)哌啶 | 795261-46-0

中文名称
3-(3-氟苄基)哌啶
中文别名
——
英文名称
3-(3-Fluorobenzyl)piperidine
英文别名
3-[(3-fluorophenyl)methyl]piperidine
3-(3-氟苄基)哌啶化学式
CAS
795261-46-0
化学式
C12H16FN
mdl
——
分子量
193.26
InChiKey
NNRHYTAYBNCEOE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    270.3±13.0 °C(Predicted)
  • 密度:
    1.044±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    12
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT

文献信息

  • [EN] TRICYCLIC COMPOUNDS FOR USE IN THE TREATMENT AND/OR CONTROL OF OBESITY<br/>[FR] COMPOSÉS TRICYCLIQUES À UTILISER DANS LE TRAITEMENT ET/OU LA LUTTE CONTRE L'OBÉSITÉ
    申请人:ZAFGEN INC
    公开号:WO2014071369A1
    公开(公告)日:2014-05-08
    The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
    这项发明提供了三环化合物及其在治疗医学疾病(如肥胖症)中的用途。提供了制备各种三环化合物的药物组合物和方法。这些化合物被认为具有对甲硫氨酸氨基肽酶2的活性。
  • Inhibitors of Ion Channels
    申请人:Marron Brian Edward
    公开号:US20130072471A1
    公开(公告)日:2013-03-21
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
    本发明提供了在通过抑制电压门控钠通道中的钠离子流来治疗疾病方面有用的化合物、组合物和方法。更具体地,本发明提供了取代芳基磺酰胺、包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或外周神经系统疾病,特别是疼痛和慢性疼痛的方法,通过阻断与所示条件的发生或复发相关的钠通道来实现。本发明的化合物、组合物和方法特别适用于通过抑制电压门控钠通道中的离子流来治疗神经病性或炎症性疼痛。
  • INHIBITORS OF ION CHANNELS
    申请人:Marron Brian Edward
    公开号:US20090143358A1
    公开(公告)日:2009-06-04
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.
    本发明提供了化合物、组合物和方法,通过抑制电压门控钠通道中的钠离子流来治疗疾病。更具体地,本发明提供了取代芳基磺酰胺、包含这些化合物的组合物,以及使用这些化合物或组合物治疗中枢或外周神经系统疾病,特别是疼痛和慢性疼痛的方法,通过阻止与所示疾病的发生或复发有关的钠通道。本发明的化合物、组合物和方法特别适用于通过抑制电压门控钠通道中的离子流来治疗神经病理性或炎症性疼痛。
  • EP1995241A1
    申请人:——
    公开号:EP1995241A1
    公开(公告)日:2008-11-26
  • Inhibitors of ion channels
    申请人:ICAgen, Inc.
    公开号:EP1995241B1
    公开(公告)日:2010-03-17
查看更多